Vitalhub (TSE:VHI – Get Free Report) had its price objective reduced by investment analysts at Raymond James Financial from C$11.00 to C$10.50 in a note issued to investors on Monday, BayStreet reports. The firm currently has an “outperform” rating on the stock. Raymond James Financial‘s target price would suggest a potential upside of 61.04% from the company’s current price.
A number of other analysts have also weighed in on VHI. Scotia cut their target price on shares of Vitalhub from C$12.00 to C$9.00 and set a “sector outperform” rating on the stock in a research note on Monday. TD reduced their target price on shares of Vitalhub from C$13.00 to C$9.50 and set a “buy” rating on the stock in a report on Monday. Canaccord Genuity Group decreased their price target on shares of Vitalhub from C$15.00 to C$14.50 and set a “buy” rating for the company in a research note on Monday. Finally, ATB Cormark Capital Markets lowered their price target on shares of Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating for the company in a report on Monday. Nine analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of C$10.86.
Read Our Latest Research Report on Vitalhub
Vitalhub Trading Down 6.9%
VHI traded down C$0.48 on Monday, hitting C$6.52. 481,442 shares of the company were exchanged, compared to its average volume of 297,780. Vitalhub has a twelve month low of C$6.46 and a twelve month high of C$9.77. The company has a market cap of C$412.97 million, a price-to-earnings ratio of 54.33, a price-to-earnings-growth ratio of 1.18 and a beta of 1.37. The firm has a 50-day moving average price of C$7.56 and a two-hundred day moving average price of C$7.58.
Vitalhub (TSE:VHI – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 earnings per share for the quarter. The company had revenue of C$31.91 million for the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. Equities analysts expect that Vitalhub will post 0.23 EPS for the current year.
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
